Edition:
India

Innovent Biologics Inc (1801.HK)

1801.HK on Hong Kong Stock

25.20HKD
19 Jul 2019
Change (% chg)

HK$0.00 (+0.00%)
Prev Close
HK$25.20
Open
HK$25.05
Day's High
HK$25.70
Day's Low
HK$24.95
Volume
1,310,704
Avg. Vol
3,052,373
52-wk High
HK$31.85
52-wk Low
HK$14.00

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Dec '18 5.04 -17.290
Jun '18 4.44 0.050
FY 2017 Dec '17 8.54 -0.403
Jun '17 10.00 -0.235
 
*Note: Units in Millions ofRenminbi
**Note: Units in Renminbi

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-19 9 578.30 741.31 380.97 --
Year Ending Dec-20 9 1,987.44 3,454.52 1,189.50 --
Earnings (per share)
Year Ending Dec-19 8 -1.32 -0.85 -1.82 --
Year Ending Dec-20 8 -0.97 -0.54 -1.38 --
Sales and Profit Figures in Hong Kong Dollar (HKD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 29.88 32.66
P/E High - Last 5 Yrs. -- 42.96 47.28
P/E Low - Last 5 Yrs. -- 23.36 23.87
Beta -- 0.89 0.89
Price to Sales (TTM) -- 6.26 7.92
Price to Book (MRQ) -- 5.26 5.38
Price to Tangible Book (MRQ) -- 5.93 6.71
Price to Cash Flow (TTM) -- 23.51 24.37
% Owned Institutions -- 0.75 1.45

Dividends

  Company industry sector
Dividend Yield -- 1.42 1.35
Dividend Yield - 5 Year Avg -- 1.45 1.38
Dividend 5 Year Growth Rate -- 3.90 4.54
Payout Ratio(TTM) -- 42.62 40.25

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 5.12 12.23
Sales (TTM) vs TTM 1 Yr. Ago -- 6.49 7.74
Sales - 5 Yr. Growth Rate -- 10.59 10.88
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 40.64 43.00
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 9.79 10.32
Capital Spending - 5 Yr. Growth Rate -- 15.44 14.84

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.11 2.21
Current Ratio (MRQ) -- 2.93 3.03
LT Debt to Equity (MRQ) -- 7.95 10.21
Total Debt to Equity (MRQ) -- 11.64 14.56
Interest Coverage (TTM) -- 32.88 29.24

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 51.83 52.21
Gross Margin - 5 Yr. Avg. -- 49.67 50.41
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 17.40 13.16
Operating Margin (TTM) -- 13.79 6.88
Operating Margin - 5 Yr. Avg. -- 13.96 8.96
Pre-Tax Margin (TTM) -- 12.42 6.08
Pre-Tax Margin - 5 Yr. Avg. -- 14.37 9.26
Net Profit Margin (TTM) -- 9.21 2.71
Net Profit Margin - 5 Yr. Avg. -- 10.81 5.63
Effective Tax Rate (TTM) -- 22.44 22.40
Effective Tax Rate - 5 Yr. Avg. -- 22.49 22.75

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 993,662,009 887,821,366
Net Income/Employee (TTM) -- 114,096,732 101,905,564
Receivable Turnover (TTM) -- 5.96 5.94
Inventory Turnover (TTM) -- 2.62 3.36
Asset Turnover (TTM) -- 0.97 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 11.51 11.18
Return on Assets - 5 Yr. Avg. -- 12.96 12.34
Return on Investment (TTM) -- 14.90 14.49
Return on Investment - 5 Yr. Avg. -- 16.86 16.03
Return on Equity (TTM) -- 16.02 15.79
Return on Equity - 5 Yr. Avg. -- 17.66 17.01

Performance for Innovent Biologics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -- -- -- 23
13 Week -- -- -- 42
26 Week -- -- -- 42
52 Week -- -- -- 12
YTD -- -- -- 38
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 42.96%
# of Holders: 42
Total Shares Held: 495,927,608
3 Mo. Net Change: 87,773,249
# New Positions: 7
# Closed Positions: 1
# Increased Positions: 15
# Reduced Positions: 6
# Net Buyers: 9
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.